Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

  • Transparency Market Research
  • October 2020
  • Cancer Diagnostics
  • 124 pages

Report Description

Global Cancer Diagnostics Market - Scope of Report

TMR’s report on the global cancer diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global cancer diagnostics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cancer diagnostics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cancer diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cancer diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cancer diagnostics market.

The report delves into the competitive landscape of the global cancer diagnostics market. Key players operating in the global cancer diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cancer diagnostics market that have been profiled in this report.

Key Questions Answered in Global Cancer Diagnostics Market Report

  • What is the scope of growth of product companies in the global cancer diagnostics market?
  • What will be the Y-o-Y growth of the global cancer diagnostics market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global cancer diagnostics market?
  • Will North America continue to be the most profitable market for cancer diagnostics providers?
  • Which factors are anticipated to hamper the growth of the global cancer diagnostics market during the forecast period?
  • Which are the leading companies in the global cancer diagnostics market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global cancer diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global cancer diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the cancer diagnostics market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cancer diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cancer diagnostics market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global cancer diagnostics market more reliably and accurately.

Regional Segmentation of Cancer Diagnostics Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Cancer Diagnostics Market – Segmentation

Method

  • Biopsy
  • Bone Marrow Biopsy
  • Needle Biopsy
  • Endoscopic Biopsy
  • Endoscopy
  • Bronchoscopy
  • Colonoscopy
  • Sigmoidoscopy
  • Colposcopy
  • Others
  • Imaging
  • MRI Scan
  • PET Scan
  • CT Scan
  • Mammography
  • Ultrasound
  • Tumor Biomarker Tests
  • PSA Tests
  • CTC Tests
  • AFP Tests
  • CA 19-9
  • CA 125
  • EGFR
  • HER2
  • CEA
  • BRCA
  • KRAS
  • ALK

Application

  • Blood Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Have query on this report?

Make an Enquiry

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objective
1.4. Research Highlight

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Diagnostics Market

4. Market Overview

4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Development
4.2. Overview
4.3. Market Dynamic
4.3.1. Driver
4.3.2. Restraint
4.3.3. Opportunitie
4.4. Global Cancer Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Regulatory Scenario and Reimbursement
5.2. Cancer Epidemiology
5.3. List of active market participants (suppliers/distributors/manufacturers/vendors)

6. Global Cancer Diagnostics Market Analysis and Forecast, by Method
6.1. Introduction & Definition
6.1.1. Key Findings / Development
6.2. Global Cancer Diagnostics Market Value Forecast, by Method, 2017–2027
6.2.1. Biopsy
6.2.1.1. Bone Marrow Biopsy
6.2.1.2. Needle Biopsy
6.2.1.3. Endoscopic Biopsy
6.2.2. Endoscopy
6.2.2.1. Bronchoscopy
6.2.2.2. Colonoscopy
6.2.2.3. Sigmoidoscopy
6.2.2.4. Colposcopy
6.2.2.5. Other
6.2.3. Imaging
6.2.3.1. MRI Scan
6.2.3.2. PET Scan
6.2.3.3. CT Scan
6.2.3.4. Mammography
6.2.3.5. Ultrasound
6.2.4. Tumor Biomarker Test
6.2.4.1. PSA Test
6.2.4.2. CTC Test
6.2.4.3. AFP Test
6.2.4.4. CA 19-9
6.2.4.5. CA 125
6.2.4.6. EGFR
6.2.4.7. HER2
6.2.4.8. CEA
6.2.4.9. BRCA
6.2.4.10. KRA
6.2.4.11. ALK
6.3. Global Cancer Diagnostics Market Attractiveness, by Method

7. Global Cancer Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.1.1. Key Findings / Development
7.2. Global Cancer Diagnostics Market Value Forecast, by Application, 2017–2027
7.2.1. Blood Cancer
7.2.2. Breast Cancer
7.2.3. Colorectal Cancer
7.2.4. Kidney Cancer
7.2.5. Liver Cancer
7.2.6. Lung Cancer
7.2.7. Ovarian Cancer
7.2.8. Pancreatic Cancer
7.2.9. Prostate Cancer
7.3. Global Cancer Diagnostics Market Attractiveness, by Application

8. Global Cancer Diagnostics Market Analysis and Forecast, by Region
8.1. Key Finding
8.2. Global Cancer Diagnostics Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Cancer Diagnostics Market Attractiveness, by Region

List of Table

Table 1 List of Abbreviation
Table 2 Market Snapshot: Global Cancer Diagnostics Market
Table 3 List of Cancer Risk Factors
Table 4 Estimated Incidence, 1 year, 2 years and 5 years survival
Table 5 Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
Table 6 Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
Table 7 Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs
Table 8 Summary of Type of Diagnostics Test in the U.S.
Table 9 Event Impact Analysis: Global Cancer Diagnostics Market, 2017-2027
Table 10 Global Cancer Diagnostics Market Revenue, by Method, 2017-2027 (USD) Million
Table 11 Global Cancer Diagnostics Market Revenue, by Application, 2017-2027 (USD) Million
Table 12 Global Cancer Diagnostics Market Revenue, by Geography, 2017-2027 (USD) Million

Success Stories

Our Clients